OTC Markets Group (OTCM) Q1 2025 earnings summary

Executive summary

• Gross revenues for Q1 2025 reached $30.4 million, up 10% year-over-year, with net income up 1% to $6.0 million and operating income up 9% to $7.3 million; diluted GAAP EPS rose 2% to $0.50.

• Key growth drivers were OTC Link and Market Data Licensing, with strategic priorities including overnight trading, OTC ID initiatives, and expanding securities listings.

• Corporate Services revenues declined 1%, but sales are trending upward due to OTC ID changes and pricing adjustments.

• Announced launch of OTC ID Basic Market in July 2025, replacing the Pink Current Market.

• $5.1 million was returned to shareholders via dividends and buybacks, unchanged year-over-year.

Financial highlights

• Gross revenues reached $30.4 million, up 10% year-over-year; revenues less transaction-based expenses rose 7% to $27.1 million.

• OTC Link gross revenues grew 22%, with a 46% increase in transaction-based revenues; Market Data Licensing revenues rose 15%.

• Operating expenses increased 6% to $19.8 million, mainly from higher compensation, consulting, and administrative costs.

• Adjusted EBITDA was $9.8 million, and adjusted diluted EPS was $0.81, both up 7%.

• Free cash flow for the quarter was negative $934,000, an improvement from negative $1.2 million a year ago.

Outlook and guidance

• Focus remains on executing overnight trading and OTC ID initiatives, with continued regulatory engagement and operational integrity.

• Management emphasizes long-term growth in earnings and free cash flow per share, with continued investment in people and platform.

• Expect to report on OTC ID compliance numbers by the next quarter, with ongoing updates on company participation.

• Second quarter 2025 dividend of $0.18 per share declared, payable June 18, 2025.